Interestingly, a subsequent study showed immunoglobulin A (IgA+) B cells that accumulate in human NASH and in multiple mouse models of NASH are able to suppress cytotoxic effects of the intrahepatic CD8+ T cells on the HCC tumor (Shalapour et al., 2017). This evidence concerns the gene CD79A and metabolic dysfunction-associated steatohepatitis.